Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sylvain Rosec"'
Autor:
I. Frachon, M.-R. Munck, A. Dirou, D. Horeau-Langlard, M.-P. Pelletier, Christopher Payan, I. Danner-Boucher, J. Caillon, G. Le Gal, Gilles Rault, J. Le Bihan, Sylvain Rosec, S. Ramel, Claude Férec, Elise Poulhazan, Emmanuel Nowak, Geneviève Héry-Arnaud, K. Revert, A. Haloun, S. Gouriou, R. Le Berre, V. David
Publikováno v:
Clinical Microbiology and Infection
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2017, 23 (3), pp.203-207
Clinical Microbiology and Infection, Elsevier for the European Society of Clinical Microbiology and Infectious Diseases, 2017, 23 (3), pp.203-207
Objectives Early detection of Pseudomonas aeruginosa lung positivity is a key element in cystic fibrosis (CF) management. PCR has increased the accuracy of detection of many microorganisms. Clinical relevance of P. aeruginosa quantitative PCR (qPCR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5f414f78134eef6ecc0918ba4e4cb0
https://hal.univ-brest.fr/hal-02048694
https://hal.univ-brest.fr/hal-02048694
Autor:
Sophie Vallet, Sylvain Rosec, S. Gouriou, Marlène Keravec, Jérôme Mounier, Gilles Rault, Emmanuel Prestat, Georges Barbier, Emmanuel Coton, Gaëtan Burgaud, Janet K. Jansson, Geneviève Héry-Arnaud
Publikováno v:
SpringerPlus
SpringerPlus, SpringerOpen, 2014, 4, pp.405. ⟨10.1186/s40064-015-1207-0⟩
SpringerPlus, SpringerOpen, 2014, 4, pp.405. ⟨10.1186/s40064-015-1207-0⟩
Pseudomonasaeruginosa plays a major role in cystic fibrosis (CF) progression. Therefore, it is important to understand the initial steps of P. aeruginosa infection. The structure and dynamics of CF respiratory tract microbial communities during the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::273701fedd84cc25a5746a45252495e8
https://doi.org/10.1186/s40064-015-1207-0
https://doi.org/10.1186/s40064-015-1207-0
Autor:
Evelyne Schvoerer, Elisabeth André-Garnier, Joël Gozlan, Etienne Brochot, Sylvie Larrat, Sébastien Hantz, Catherine Gaudy-Graffin, Hélène Le Guillou-Guillemette, Nelly Magnat, Vincent Mackiewicz, Syria Laperche, Jean-Christophe Plantier, Philippe Colson, Françoise Lunel-Fabiani, Patrick Soussan, Gisèle Lagathu, Christopher Payan, Jacques Izopet, Sylvain Rosec, S. Gouriou, Anne-Marie Roque-Afonso, Patrice Morand, Caroline Scholtes, Adeline Pivert, Sophie Vallet, Florence Legrand-Abravanel, Vincent Thibault, Sarah Maylin, Audrey Mirand, Stéphane Chevaliez, Jean-Michel Pawlotsky, Charlotte Charpentier, Valérie Giordanengo, Cécile Henquell, Françoise Bouchardeau, Lina Aguilera, Pascale Trimoulet
Publikováno v:
Journal of Clinical Microbiology
Journal of Clinical Microbiology, American Society for Microbiology, 2013, 51 (5), pp.1428-33. ⟨10.1128/JCM.03032-12⟩
Journal of Clinical Microbiology, 2013, 51 (5), pp.1428-33. ⟨10.1128/JCM.03032-12⟩
Journal of Clinical Microbiology, American Society for Microbiology, 2013, 51 (5), pp.1428-33. ⟨10.1128/JCM.03032-12⟩
Journal of Clinical Microbiology, 2013, 51 (5), pp.1428-33. ⟨10.1128/JCM.03032-12⟩
Hepatitis C virus (HCV) protease inhibitor resistance-associated substitutions are selected during triple-therapy breakthrough. This multicenter quality control study evaluated the expertise of 23 French laboratories in HCV protease inhibitor resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9d6f080641c9f4ff6e92ecd17292335
https://hal.univ-brest.fr/hal-00935958
https://hal.univ-brest.fr/hal-00935958
Autor:
Jeanne Hardy, Sylvie Boisramé-Gastrin, S. Gouriou, Christopher Payan, Florence Le Gall, Rozenn Le Berre, Sylvain Rosec, Sophie Vallet, Gilles Rault, Geneviève Héry-Arnaud
Publikováno v:
BMC Microbiology
BMC Microbiology, BioMed Central, 2013, 13 (1), pp.143
BMC Microbiology, BioMed Central, 2013, 13, pp.143. ⟨10.1186/1471-2180-13-143⟩
BMC Microbiology, BioMed Central, 2013, 13 (1), pp.143
BMC Microbiology, BioMed Central, 2013, 13, pp.143. ⟨10.1186/1471-2180-13-143⟩
Background The lung of patients with cystic fibrosis (CF) is particularly sensitive to Pseudomonas aeruginosa. This bacterium plays an important role in the poor outcome of CF patients. During the disease progress, first acquisition of P. aeruginosa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bc8203df3bfe2f859a640ce39f7acb9
https://www.hal.inserm.fr/inserm-00837789/file/1471-2180-13-143.pdf
https://www.hal.inserm.fr/inserm-00837789/file/1471-2180-13-143.pdf
Autor:
Marlène Keravec, Gilles Rault, Sylvain Rosec, Jérôme Mounier, G. Barbier, Geneviève Héry-Arnaud, R. Le Berre, S. Gouriou
Publikováno v:
Journal of Cystic Fibrosis. :S74
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c0d2ae2dae610fc04d40585f34a6f68